Senior Clinical Scientist Jobs in Cambridge, MA at Acceleron Pharma
Title: Senior Clinical Scientist
Company: Acceleron Pharma
Location: Cambridge, MA
Salary: $80K — $100K *
Category: Pharmaceuticals & Biotech
What’s in it for you?
We are seeking a talented and passionate individual to join our dynamic clinical team. In this role, you will be responsible for providing scientific support for clinical development activities for drug products in pulmonary diseases. Reporting to the Senior Director of Clinical Science, you will collaborate closely with the pulmonary Medical Director, clinical pharmacology, program management, clinical operations, biostatistics, and data management groups. This cross-functional role includes assembling, evaluating, and presenting scientific and medical data, assisting with writing manuscripts (paper, abstracts, posters, etc.), and reviewing and summarizing relevant literature. Responsibilities will also include biomarker analysis, data review and trial startup activities for future studies.
You will contribute to the creation and maintenance of a clinical development plan for sotatercept and other potential drug candidates in pulmonary disease. Applying your strong scientific background with a focus in pulmonary disease and translational medicine, you will clearly communicate concepts and information both in writing and via formal presentations to scientific and medical experts both internally and externally. Someone who can think creatively, function independently, has good strategic insights and knowledge of the activities and procedures involved in clinical drug development and translational science, while having fun along the way, would be a great fit for our group!
What will you be doing?
Developing and implementing biomarker strategies for pulmonary studies
Providing scientific input to clinical trial protocol development and helping define efficacy and safety endpoints for pulmonary studies
Participating in the generation of case report forms for future studies to ensure we are collecting all necessary information in the most appropriate way
Understanding competitive landscape and providing insights on strategic development plans
Working as part of an integrated drug development team, you will contribute to the clinical strategy and creation of the clinical development plans for pulmonary indications for one or more drugs
Collaborating with the clinical development team on the review, analysis, and interpretation of study results, including exploratory endpoints and assuring appropriate data review and accurate data reporting
Preparing data and contributing to scientific publications including posters, abstracts and manuscripts
Supporting the Medical Monitor with the development of program documents, including the clinical sections of various regulatory documents such as clinical study reports, investigator brochures, annual reports and updates, and clinical sections of regulatory submissions to support product approvals
Participating in the identification of appropriate external investigators and consultants
Anticipating potential study problems and preparing contingency plans as needed
Developing and cultivating relationships with external partners such as clinical investigators, clinicians, scientists, and vendors
Providing support to advisory boards, consultant meetings and investigator meetings, including preparation and delivery of presentations
Proactively seeking out and recommending process improvements
Communicating clearly and precisely with all levels of the company globally
Providing scientific input to the preclinical pharmacology team for translational s…
About Acceleron Pharma
Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Boston, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-ß) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. John Knopf, Jasbir Seehra, Tom Maniatis, Mark Ptashne and Wylie Vale formed the company in Cambridge, Massachusetts. The company began with a venture capital investment and opened its first laboratory in December 2003. The company tendered an initial public offering in September 2013.